Search results for " Modality"

showing 10 items of 461 documents

Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies.

2013

Cancer of the pancreas is the second most frequent digestive cancer in the US, accounting for about 44,000 new cases per year. In Europe, it is the sixth most frequent cancer, accounting for 2.8% of cancers in men and 3.2% in women. With a five-year survival of less than 10%, it is the fifth leading cause of cancer-related death. The majority of cases are diagnosed above the age of 65 and in about 60% of cases at an advanced stage, explaining that little improvement has been observed in survival over the past 30 years. Radical surgery offers the only curative treatment of pancreatic cancer. Alternative or combined therapeutic options in particular consist of adjuvant or neoadjuvant chemothe…

Oncologymedicine.medical_specialtyCost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisAntineoplastic AgentsQuality of lifePancreatic cancerInternal medicineAdjuvant therapyMedicineCombined Modality TherapyHumansRadical surgeryIntensive care medicineDigestive System Surgical Proceduresbusiness.industryPalliative CareGastroenterologyCancermedicine.diseaseCombined Modality TherapyRadiation therapyEconomics MedicalEuropePancreatic NeoplasmsQuality of LifeHealth ResourcesbusinessBest practiceresearch. Clinical gastroenterology
researchProduct

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies a…

2019

Of the two human herpesvirus 6 (HHV-6) species, human herpesvirus 6B (HHV-6B) encephalitis is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplant. Guidelines for the management of HHV-6 infections in patients with hematologic malignancies or post-transplant were prepared a decade ago but there have been no other guidelines since then despite significant advances in the understanding of HHV-6 encephalitis, its therapy, and other aspects of HHV-6 disease in this patient population. Revised guidelines prepared at the 2017 European Conference on Infections in Leukaemia covering diagnosis, preventative strategies and management of HHV-6 disease are n…

Oncologymedicine.medical_specialtyHHV-6 Infectionmedicine.medical_treatmentvirusesHerpesvirus 6 HumanGraft vs Host DiseaseRoseolovirus InfectionsDiseaseHematopoietic stem cell transplantationAntiviral AgentsGuideline ArticleImmunocompromised HostInternal medicinemedicineCombined Modality TherapyHumansIn patientbiologybusiness.industryHematopoietic Stem Cell Transplantationvirus diseasesHematologybiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseCell Transformation ViralCombined Modality TherapyEuropeTreatment OutcomeHematologic NeoplasmsPractice Guidelines as TopicHuman herpesvirus 6Allogeneic hematopoietic stem cell transplantbusinessEncephalitisHaematologica
researchProduct

Multidisciplinary management of gastric and gastroesophageal cancers

2008

Carcinomas of the stomach and gastroesophageal junction are among the five top leading cancer types worldwide. In spite of radical surgical R0 resections being the basis of cure of gastric cancer, surgery alone provides long-term survival in only 30% of patients with advanced International Union Against Cancer (UICC) stages in Western countries because of the high risk of recurrence and metachronous metastases. However, recent large phase-III studies improved the diagnostic and therapeutic options in gastric cancers, indicating a more multidisciplinary management of the disease. Multimodal strategies combining different neoadjuvant and/or adjuvant protocols have clearly improved the gastric…

Oncologymedicine.medical_specialtyPalliative careEsophageal Neoplasmsmedicine.medical_treatmentDiseaseStomach NeoplasmsInternal medicinemedicineAdjuvant therapyHumansCombined Modality TherapyNeoadjuvant therapyChemotherapybusiness.industryGeneral surgeryPalliative CareGastroenterologyCancerGeneral MedicinePerioperativemedicine.diseaseCombined Modality TherapyNeoadjuvant TherapyEditorialChemotherapy AdjuvantEsophagogastric JunctionbusinessWorld Journal of Gastroenterology
researchProduct

Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.

2009

Head & Neck Cancer (HNC) represents the sixth most common malignancy worldwide and it is historically linked to well-known behavioural risk factors, i.e., tobacco smoking and/or the alcohol consumption. Recently, substantial evidence has been mounting that Human Papillomavirus (HPV) infection is playing an increasing important role in oral cancer. Because of the attention and clamor surrounding oral HPV infection and related cancers, as well as the use of HPV prophylactic vaccines, in this invited perspective the authors raise some questions and review some controversial issues on HPV infection and its role in HNC, with a particular focus on oral squamous cell carcinoma. The problematic def…

Oncologymedicine.medical_specialtyPathologyMalignancyPapillomavirus VaccinesInternal medicineHumansMedicineHuman papilloma virus infectionHPV infection;oral cancer;Papillomavirus VaccinesMouth neoplasmbusiness.industryTransmission (medicine)Papillomavirus InfectionsHPV infectionvirus diseasesCancerGenetic Therapyoral cancerPrognosismedicine.diseaseCombined Modality Therapyfemale genital diseases and pregnancy complicationsstomatognathic diseasesOncologyOtorhinolaryngologyOtorhinolaryngologyHead and Neck NeoplasmsHPV infectionCommentaryMouth Neoplasmsbusiness
researchProduct

Fertility sparing treatments in endometrial cancer patients: the potential role of the new molecular classification

2021

Endometrial cancer is the most frequent gynecological malignancy, and, although epidemiologically it mainly affects advanced age women, it can also affect young patients who want children and who have not yet completed their procreative project. Fertility sparing treatments are the subject of many studies and research in continuous evolution, and represent a light of hope for young cancer patients who find themselves having to face an oncological path before fulfilling their desire for motherhood. The advances in molecular biology and the more precise clinical and prognostic classification of endometrial cancer based on the 2013 The Cancer Genome Atlas classification allow for the selection…

Oncologymedicine.medical_specialtyQH301-705.5obstetric outcomesReviewHysteroscopyCatalysisFertility sparing surgeryInorganic ChemistryMolecular classificationPrognostic classificationInternal medicineCancer genomeOutcome Assessment Health CaremedicineHumansmolecular biologyPhysical and Theoretical ChemistryBiology (General)QD1-999SpectroscopyPregnancybusiness.industryEndometrial cancerOrganic ChemistryFertility PreservationCancerGeneral Medicinemedicine.diseaseEndometrial cancer; Fertility sparing; Molecular biology; Obstetric outcomes; PregnancyCombined Modality Therapyfertility sparingEndometrial NeoplasmsComputer Science Applicationsendometrial cancer; molecular biology; fertility sparing; obstetric outcomes; pregnancyChemistryFertilityGynecological malignancyendometrial cancerFemalepregnancyProgestinsbusinessOrgan Sparing Treatments
researchProduct

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selecte…

2021

BACKGROUND: The advent of immuno-oncology (IO) represented a breakthrough in non-small cell lung cancer (NSCLC) therapy over the last few years. However, establishing the optimal therapeutic options among programmed death-ligand 1 (PD-L1) selected subgroups still addresses an unmet need in the clinical setting. METHODS: We performed a systematic review and finally included eleven first-line randomized controlled trials to compare efficacy and safety outcomes among first-line IO treatment strategies versus standard platinum-based chemotherapy (CT) according to PD-L1 expression level (<1%, 1–49%, ≥50%). Pooled hazard ratios (HRs) and risk ratios (RRs) for progression-free survival (PFS), over…

Oncologymedicine.medical_specialtyprogrammed death-1/cytotoxic T-lymphocyte antigen 4 inhibitors (PD-1/CTLA-4 inhibitors)combined modality therapybusiness.industryHazard ratioCombined modality therapy; Immunotherapy; Meta-analysis; Non-small cell lung cancer (NSCLC); Programmed death-1/cytotoxic T-lymphocyte antigen 4 inhibitors (PD-1/CTLA-4 inhibitors)non-small cell lung cancer (NSCLC)Non-small cell lung cancer (NSCLC)medicine.diseaselaw.inventionDiscontinuationmeta-analysisOncologyRandomized controlled triallawRelative riskInternal medicineMeta-analysisMedicineOriginal ArticleimmunotherapybusinessLung cancerAdverse effect
researchProduct

Update endokrine Orbitopathie

2009

Ophthalmologymedicine.medical_specialtymedicine.diagnostic_testDecompressionPractice patternsbusiness.industrymedicineMEDLINECombined Modality TherapyRadiologybusinessThyroid function testsSurgical methodsKlinische Monatsblätter für Augenheilkunde
researchProduct

Lip repositioning technique. A simple surgical procedure to improve the smile harmony

2018

Excessive gingival display is an esthetic concern for patients. It is a condition in which an overexposure of the maxillary gingiva (>3mm) is present during smiling. There are different etiologies of a gummy smile, such as vertical maxillary excess, short and hyperactive upper lip, altered passive eruption, anterior dentoalveolar extrusion, or a combination of these causes. The correct diagnosis of all etiologic factors is imperative for its appropriate management. Many techniques have been used to restore the dentogingival relation for the management of gummy smile. Lip repositioning is a conservative surgical technique used to treat excess gingival display. It is a largely unknown treatme…

Orthodonticsbusiness.industrymedicine.medical_treatmentVertical maxillary excessUpper lipOrthognathic surgeryCase Report030206 dentistrystomatognathic diseases03 medical and health sciences0302 clinical medicinestomatognathic systemTreatment modalityGummy smileMedicineOral SurgerybusinessGeneral DentistryMaxillary gingiva030217 neurology & neurosurgeryJournal of Clinical and Experimental Dentistry
researchProduct

Neural networks engaged in milliseconds and seconds time processing: evidence from transcranial magnetic stimulation and patients with cortical or su…

2009

Here, we review recent transcranial magnetic stimulation studies and investigations in patients with neurological disease such as Parkinson's disease and stroke, showing that the neural processing of time requires the activity of wide range-distributed brain networks. The neural activity of the cerebellum seems most crucial when subjects are required to quickly estimate the passage of brief intervals, and when time is computed in relation to precise salient events. Conversely, the circuits involving the striatum and the substantia nigra projecting to the prefrontal cortex (PFC) are mostly implicated in supra-second time intervals and when time is processed in conjunction with other cognitiv…

Parkinson's diseaseNerve netParkinson's diseaseRepetitive transcranial magnetic stimulationmedicine.medical_treatmentParkinson's disease; Repetitive transcranial magnetic stimulation; Stroke; Time perception; Timing; Transcranial magnetic stimulation;Time perceptionReviewGeneral Biochemistry Genetics and Molecular BiologyNOStimulus modalityCerebral Cortex; Humans; Time Perception; Brain Diseases; Transcranial Magnetic Stimulation; Nerve NetmedicineHumansTimingBRAINPrefrontal cortexCerebral CortexBrain DiseasesSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryCognitionTime perceptionmedicine.diseaseTIMEStrokeTranscranial magnetic stimulationmedicine.anatomical_structureCerebral cortexSettore MED/26 - NeurologiaNerve NetGeneral Agricultural and Biological SciencesbusinessNeuroscienceTranscranial magnetic stimulationPhilosophical Transactions of the Royal Society B: Biological Sciences
researchProduct

Lack of Association Between Tumor Hypoxia, Glut-1 Expression and Glucose Uptake in Experimental Sarcomas

2003

Hypoxia is a common phenomenon in experimental and human tumors which not only limits the efficacy of non-surgical treatment modalities such as irradiation and 02-dependent chemotherapy but also affects the long-term prognosis of cancer patients. Numerous studies have clearly demonstrated that patients with more hypoxic tumors have a reduced probability for survival and disease-free survival’. For this reason it might be helpful to non-invasively identify patients with hypoxic malignancies.

Pathologymedicine.medical_specialtyChemotherapyTumor hypoxiaTreatment modalitymedicine.medical_treatmentGlucose uptakeCancer researchmedicineBiologyHypoxia (medical)medicine.symptom
researchProduct